A YouTube episode hosted by Marcelle Pick that explains and evaluates the new generation of weight-loss drugs (Ozempic, Mounjaro, ZepBound/Wegovy). The host compares mechanisms (GLP-1 vs dual GLP-1/GIP tirzepatide), highlights that these drugs may require long-term use because studies show about two-thirds of people regain weight after stopping, and stresses the need for holistic care (diet, behavior change, psychological support). Practical tips mentioned include increasing protein to ~30 g per meal to preserve muscle while losing weight. The transcript includes some misspellings of company/product names.
Questions this video answers
"Nova Dordisk" (as stated in the transcript).
About two-thirds (≈ 2/3).
Up to 30 grams per meal.
Chapters
I'm Marcel Pick, I'm your host. And this is where we actually going to dissect the complexities of modern medical advancements today. Specifically, we're going to be delving into a highly topical issue in the world of medicine, the new generation of weight loss drugs. We're actually going to focus on understanding the nuances which come out every day and long term implications of treatments like the Ozempic, Monjaro and the newest Zepbound. Join us as we explore these groundbreaking drugs in great depth. Ozempic was actually developed by Nova Dordisk and it has made headlines for its role in wheat management worldwide. Alongside its original purpose for type 2 diabetes treatment. This actually led to the development of Wegovy, a high dose semi glutide specifically for obesity. However, an important aspect to consider is a long term commitment these drugs may require. As studies to date have shown that about 2/3 of individuals could regain their weight once they stop using their medication. There's a real rebound that occurs with this. Turning our focus on Eli Lilly's contributions, Manjaro and Zepbound, the newest one to come to the market, we see a fascinating development in this field. Monjuro, containing Triazepatide has unique dualistic mechanisms. It not only mimics the GLP1 hormones which suppress appetite, but also the GIP hormone. This dual action enhances effectiveness, affect your blood sugar and aids in weight loss significantly. And E. Lilly leveraged his success to actually create Zeppelin, a drug specifically for chronic weight management that also uses a tricep aside. And the key differences lie in Zeppelin focuses on weight management, while Monjiro is primarily a diabetes medication with weight loss as its significant benefit. So these medications actually represent a significant leap, as you all know, in the weight loss treatment. Yet they really come with a caveat. This is what I want you to pay attention to. The concern of weight regain is prominent with many facing the possibility of needing these medications indefinitely and with the long term effects still largely unknown. Very important to remember there's an air of uncertainty around their prolonged use. Now the cost and availability of these medications also are really raising crucial questions. Their popularity, especially for off label use, has driven up demand, affecting supply and raising significant ethical issues about access to these potentially life changing medications. So addressing obesity, which is a condition influenced by so many factors, it's really clear that while medications like Ozempic, Mongero and Zepbound can be part of a solution, they are certainly not the panacea, which is what everybody's saying they are. So we really need more of a holistic approach encompassing lifestyle changes, psychological support and a sustainable long term strategy. It's absolutely essential. So today's episode really brought us closer to understanding the nuanced world of these weight loss medications. But I'm here to tell you that they're not all that they were cut out to be. We know that if you don't change your diet, you'll actually have significant muscle loss. So increasing protein up to 30 grams per meal is crucial to maintain muscle mass. But what we see with these medications is that it also for many, causes them to have a very significant distaste of food, which in the long run may not be sustainable. So really looking at lifestyle, we have to change our diet, we have to look at some of the psychological reasons that we might be eating so that we can really understand that long term weight loss is all about about changing behavior. It's changing how you think about food. The wonderful thing these medications have done is it helps us understand that there are people that don't know what their full period is. They also are hungry all the time. So we absolutely need to have tools that will help them with this to be able to get their diet changed and to have long term health benefits. If we don't change our diet, even if we lose weight and eat less, we're not getting healthier in the long run. So if you enjoyed this episode, stay tuned for more to come and you can also follow us and share this with other people that you think might be interested in this.